In this interview, Manpreet Kohli, MD, discusses the incorporation of bioimpedance spectroscopy into NAPBC standards, the impact of early lymphedema detection on survivorship, and how clinicians can better support patient-centered care throughout the breast cancer journey.
Hi, my name is Dr Manpreet Kohli. I am the director of breast surgery at Monmouth Medical Center in Long Branch, New Jersey, and I'm part of the advisory board for ImpediMed.
Having NAPBC accreditation is something that we're really proud to say we have because it means that we're functioning at the highest level according to the high standard of care within the field. This means that providers must push themselves to strive for the very best for the patient's benefit, because the whole importance of taking care of patients with breast cancer is not only getting them through the diagnosis but also providing them with an excellent long-term prognosis.
Read full article at www.hmpgloballearningnetwork.com/